These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1210 related items for PubMed ID: 23291258

  • 21. Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial).
    Kocher F, Pircher A, Mohn-Staudner A, Romeder F, Duller W, Steinmaurer M, Eckmayr J, Schmid T, Hilbe W, Fiegl M, Greil R.
    Lung Cancer; 2014 Sep; 85(3):395-400. PubMed ID: 25043642
    [Abstract] [Full Text] [Related]

  • 22. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Berghmans T, Lafitte JJ, Thiriaux J, VanHoutte P, Lecomte J, Efremidis A, Koumakis G, Giner V, Richez M, Corhay JL, Wackenier P, Lothaire P, Mommen P, Ninane V, Sculier JP, European Lung Cancer Working Party.
    Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
    [Abstract] [Full Text] [Related]

  • 23. A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer.
    Lv C, Ma Y, Wu N, Yan S, Zheng Q, Sun Y, Li S, Fang J, Yang Y.
    World J Surg Oncol; 2013 Mar 21; 11():76. PubMed ID: 23517534
    [Abstract] [Full Text] [Related]

  • 24. Comparison of patient outcomes according to histology among pemetrexed-treated patients with stage IIIB/IV non-small-cell lung cancer in two phase II trials.
    Zinner RG, Novello S, Peng G, Herbst R, Obasaju C, Scagliotti G.
    Clin Lung Cancer; 2010 Mar 01; 11(2):126-31. PubMed ID: 20199979
    [Abstract] [Full Text] [Related]

  • 25. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M, Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
    Lung Cancer; 2005 Jul 01; 49(1):85-94. PubMed ID: 15949594
    [Abstract] [Full Text] [Related]

  • 26. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
    Segawa Y, Kiura K, Takigawa N, Kamei H, Harita S, Hiraki S, Watanabe Y, Sugimoto K, Shibayama T, Yonei T, Ueoka H, Takemoto M, Kanazawa S, Takata I, Nogami N, Hotta K, Hiraki A, Tabata M, Matsuo K, Tanimoto M.
    J Clin Oncol; 2010 Jul 10; 28(20):3299-306. PubMed ID: 20530281
    [Abstract] [Full Text] [Related]

  • 27. Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer.
    Besse B, Planchard D, Veillard AS, Taillade L, Khayat D, Ducourtieux M, Pignon JP, Lumbroso J, Lafontaine C, Mathiot C, Soria JC.
    Lung Cancer; 2012 Apr 10; 76(1):78-83. PubMed ID: 22186627
    [Abstract] [Full Text] [Related]

  • 28. Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer.
    Campeau MP, Herschtal A, Wheeler G, Mac Manus M, Wirth A, Michael M, Hogg A, Drummond E, Ball D.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1371-5. PubMed ID: 19250769
    [Abstract] [Full Text] [Related]

  • 29. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec Barthes F, Dujon A, Danel C.
    Ann Thorac Surg; 2005 Jan 01; 79(1):225-33. PubMed ID: 15620948
    [Abstract] [Full Text] [Related]

  • 30. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM.
    Cancer; 2009 Sep 15; 115(18):4156-66. PubMed ID: 19551884
    [Abstract] [Full Text] [Related]

  • 31. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
    Yang KL, Chang YC, Ko HL, Chi MS, Wang HE, Hsu PS, Lin CC, Yeh DY, Kao SJ, Jiang JS, Chi KH.
    Clin Lung Cancer; 2016 Nov 15; 17(6):550-557. PubMed ID: 27378175
    [Abstract] [Full Text] [Related]

  • 32. Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II study.
    Aydiner A, Sen F, Saglam EK, Oral EN, Eralp Y, Tas F, Toker A, Dilege S.
    Clin Lung Cancer; 2011 Sep 15; 12(5):286-92. PubMed ID: 21729649
    [Abstract] [Full Text] [Related]

  • 33. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer].
    Liu JW, Li J, Lin G, Shang XQ.
    Zhonghua Zhong Liu Za Zhi; 2013 Jan 15; 35(1):50-3. PubMed ID: 23648301
    [Abstract] [Full Text] [Related]

  • 34. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
    Ito M, Yamashita Y, Miyata Y, Ohara M, Tsutani Y, Ikeda T, Misumi K, Harada H, Omori K.
    Lung Cancer; 2012 Apr 15; 76(1):93-7. PubMed ID: 22285532
    [Abstract] [Full Text] [Related]

  • 35. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G, Verderi E, Zuin A, Schiavon M, Battistella L, Perissinotto E, Romanello P, Favaretto AG, Pasello G, Rea F.
    Interact Cardiovasc Thorac Surg; 2014 Aug 15; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [Abstract] [Full Text] [Related]

  • 36. Survival and recurrence patterns after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophagogastric adenocarcinoma.
    Sudarshan M, Alcindor T, Ades S, Aloraini A, van Huyse M, Asselah J, David M, Frechette D, Brisson S, Thirlwell M, Ferri L.
    Ann Surg Oncol; 2015 Jan 15; 22(1):324-30. PubMed ID: 25023544
    [Abstract] [Full Text] [Related]

  • 37. Outcomes after adjuvant platinum-based chemotherapy in elderly NSCLC patients with T4 disease.
    Sigel K, Mhango G, Cohen J, Halm EA, Mandeli J, Strauss G, Wisnivesky J.
    Ann Surg Oncol; 2013 Mar 15; 20(3):1013-9. PubMed ID: 23115004
    [Abstract] [Full Text] [Related]

  • 38. Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy.
    William WN, Pataer A, Kalhor N, Correa AM, Rice DC, Wistuba II, Heymach J, Lee JJ, Kim ES, Munden R, Gold KA, Papadimitrakopoulou V, Swisher SG, Erasmus JJ, University of Texas M.D. Anderson Lung Cancer Collaborative Research Group.
    J Thorac Oncol; 2013 Feb 15; 8(2):222-8. PubMed ID: 23287849
    [Abstract] [Full Text] [Related]

  • 39. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X, Lin D, Low C, Vucic EA, English JC, Yee J, Murray N, Lam WL, Ling V, Lam S, Gout PW, Wang Y.
    J Thorac Oncol; 2013 Feb 15; 8(2):161-70. PubMed ID: 23287853
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.